Related Experiment Video
Updated: Jan 7, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
An Exploratory Study of Machine Learning-Based Open-Angle Glaucoma Detection Using Specific Autoantibodies
Naoko Takada1, Makoto Ishikawa1,2, Takahiro Ninomiya1
1Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.
None:
Objectives: Previously, we identified four open-angle glaucoma (OAG)-associated autoantibodies (anti-ETNK1, anti-VMAC, anti-NEXN, and anti-SUN1) using proteome-wide autoantibody screening by wet protein arrays. The objective of this exploratory study was to evaluate the diagnostic performance of these four glaucoma-associated autoantibodies using automated machine learning. Methods: Plasma samples from 119 patients with OAG and 35 patients with cataracts as controls were enrolled for the study. All machine-learning analyses were performed in Python 3.9.16 (GCC 11.2.0) using scikit-learn 1.2.2 and PyCaret 3.0.1. Variables included plasma levels of the autoantibodies, age, sex, and intra-ocular pressure (IOP). Probability calibration (Platt/sigmoid and isotonic) was assessed with reliability curves and Brier scores. Model explainability was examined with permutation importance, SHAP values, and an ablation analysis removing one autoantibody at a time. Results: The tuned random forest achieved an out-of-fold (OOF) area under the receiver-operating characteristic curve (ROC-AUC) of 0.852 (±0.040), an average precision (AP) of 0.950, and an F1 score of 0.865. Isotonic mapping improved agreement between predicted and empirical probabilities. Among these four autoantibodies, VMAC was the most important factor for the model's prediction. Conclusions: A machine learning model using four autoantibodies from blood samples showed potential for diagnosing OAG.
More Related Videos
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview

